Showing results (1171-1180 of 1,200) with videos related to
Sort By:
Pageof 120
American Journal of Human Genetics|May 14, 2024
Missense variants in ANO4 cause sporadic encephalopathic or familial epilepsy with evidence for a dominant-negative effectFang Yang, Anais Begemann, Nadine Reichhart, et al.Msphere|February 24, 2025
Neonatal administration of Lactiplantibacillus plantarum ATCC 202195 with or without fructooligosaccharide in Bangladesh: a placebo-controlled randomized trialLisa G Pell, Huma Qamar, Diego G Bassani, et al.Science Immunology|July 7, 2023
Restoring tumor immunogenicity with dendritic cell reprogrammingOlga Zimmermannova, Alexandra G Ferreira, Ervin Ascic, et al.Cancer Research|May 14, 2025
SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancerXianbing Zhu, Zheng Fu, Giulio Aceto, et al.Nanomaterials (Basel, Switzerland)|September 26, 2025
Sustainable Materials for EnergyFilippo Agresti, Giuliano Angella, Humaira Arshad, et al.Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.BMJ Public Health|July 15, 2025
Severe infection incidence among young infants in Dhaka, Bangladesh: an observational cohort studyAlastair Fung, Cole Heasley, Lisa G Pell, et al.European Journal of Cancer (Oxford, England : 1990)|September 8, 2017
Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centresP A van Dam, M Tomatis, L Marotti, et al.Cell Reports|July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STINGMarine Bruand, David Barras, Marco Mina, et al.Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.Pageof 120